BTK is also expressed by other immune cells, including myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs), and its immune regulatory effect on myeloid cells has an important impact on the tumor microenvironment (TME) 2. This evidence concerns the gene BTK and neoplasm.